1. Qualitative and quantitative analysis of Arnebiae Radix and Dictamni Cortex and efficacy study of herbal extracts on allergic contact dermatitis using 3D human reconstructed epidermis
Huan LI ; Esther LIM ; Gladys ANG ; Zhi-qing LIM ; Martin Hui CAI ; Jo-anne LOH ; Celine NG ; Peijia SEETOH ; Edmund TIAN ; Lay Beng GOH ; Jo-anne LOH ; Lay Beng GOH
Chinese Herbal Medicines 2021;13(4):556-564
Objective: To evaluate the quality of Arnebiae Radix (AR) and Dictamni Cortex (DC) and study the efficacy of herbal extracts of these two herbs on the treatment of allergic contact dermatitis (ACD). Methods: Qualitative and quantitative analysis of effective components was performed using High Performance Thin Layer Chromatography (HPTLC), High Performance Liquid Chromatography (HPLC), and HPLC-Quadrupole Time of Flight-Mass Spectrometry (HPLC-QTOF-MS). In vitro allergic ACD 3D model was established by incubating 3D reconstructed human epidermis (RHE) with skin sensitizer, potassium dichromate. A total of 65 gene expression that were associated with ACD, which included 24 antioxidant responsive element (ARE) and 41 SENS-IS genes were quantified by qRT-PCR. More than or equal to 10 ARE genes and 18 SENN-IS genes were induced by 1.3-fold, demonstrating the successful establishment of in vitro ACD model. Oil extracts of AR and DC were applied on the in vitro ACD model to study the efficacy. Results: Batch 3 of AR and batch 2 of DC showed presence of all active ingredients with the highest concentrations. Active ingredients of the herbs were extracted using a special oil and formulated into herbal oil extracts. The herbal oil extracts were able to down regulate the induced genes in the in-vitro ACD skin model, bringing the tissue back to homeostatic status. Conclusion: The oil extracts showed the potent efficacy of using AR and DC in ACD treatment. The combination study will be done to optimize the formulation ratio which will be developed into a topical cream.
2.Stroke Code Implementation in A Physician-Led District Hospital in Malaysia
Zainura Che Isa ; Jo Anne Lim ; Aik Kheng Lee ; Yong Chieh Chan ; Huan Yean Kang ; Aznita Ibrahim
Malaysian Journal of Medicine and Health Sciences 2022;18(No.6):108-114
Introduction: The past few years have shown a marked improvement in acute ischaemic stroke (AIS) thrombolysis therapy in Malaysia. We analysed our data on stroke code activation performed in a non-neurologist hospital.
Methods: Data of all stroke code activated patients from September 2019 to September 2020 was collected. Demographic, clinical characteristics and outcomes of these patients were analysed and reviewed with published data
in Malaysia. Results: Seventy cases were stroke code activated. Majority of the stroke cases (80%) were ischaemic
in nature with the highest subgroups of lacunar infarct at 60.7%. Hypertension is the most prevalent risk factor followed by dyslipidaemia and diabetes. The median time for onset-to-door was 95minutes, door-to-CT was 24minutes,
door-to-decision was 46.5 minutes and door-to-needle was 80minutes. There was a sequential reduction in median door-to-CT and door-to-needle time to 16.5 and 65.5minutes respectively. Fifteen patients (21.4%) were given
thrombolysis therapy. The median NIHSS score was 7.5 on arrival and 6 upon discharge. They had an improvement
of mRS from a median of 4 upon discharge to 1 at six months follow-up. There were no haemorrhage incidences post
thrombolysis. The outcome of LACI strokes versus non-LACI strokes was similar at 3 and 6-months follow-up despite
non-LACI strokes having a more severe presentation upon admission. Conclusion: With AIS thrombolysis therapy,
non-LACI strokes may have similar functional outcomes as LACI strokes. With backup support from hospitals with
neurologists and neurosurgeons, physician-led AIS thrombolysis therapy is implementable in a non-neurologist centre. Strong adherence to protocol is pertinent to ensure success.
3.Successful Conservative Treatment of Massive Infective Endocarditis with Severe Mitral Valve Regurgitation and Septic Emboli
W Yus Haniff W Isa ; Jo Anne Lim ; Jin Teng Wu ; Roberto Angelo Mojolou ; Abdul Hanan Abdullah @Mohd Baharudin
Malaysian Journal of Medicine and Health Sciences 2021;17(No.3):315-318
Management of complicated massive infective endocarditis (IE) in patients who are contraindicated for surgical valve
replacement has long been a dilemma for many clinicians. Studies have shown that massive IE patients who were
treated conservatively generally result in poorer prognosis. We report two cases of massive native valve infective endocarditis with severe mitral valve regurgitation and septic emboli that has been successfully treated conservatively.
Interestingly, despite having a large vegetation and multiple septic emboli complications, none of these two cases
had any positive culture or serology. Managing culture negative IE without surgical intervention pose an even greater
challenge to the choice and duration of antibiotics with further long-term plans. We hope to share these case series
to aid in the management dilemma of similar cases in the future.